🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › New Jersey › Newark

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Newark, NJ

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Newark. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Nagre-recruitPhase 1
  • ALX Center 12, Morristown · 17 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07085091

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Nagre-recruitPhase 3
  • Morristown Medical Center (MMCORC), Morristown · 17 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06881784

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3
  • Essex Oncology of North Jersey, Belleville · 4 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07144280

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Nagre-recruitPhase 3
  • Atlantic Health Morristown Medical Center ( Site 0077), Morristown · 17 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06312137

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Nagre-recruitPhase 3
  • Local Institution - 0507, Morristown · 17 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06561386

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Nagre-recruitPhase 2/3
  • Summit Medical Group PA, Florham Park · 12 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06712316

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Nagre-recruitPhase 1
  • Atlantic Health, Morristown · 17 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT04913285

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Nagre-recruitPhase 1/2
  • Regional Cancer Care Associates, Belleville · 4 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06892548

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Nagre-recruitObservasyonal na pag-aaral
  • Morristown Medical Center, Morristown · 17 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06418204

GEMINI-NSCLC: NSCLC Biomarker Study

Nagre-recruitObservasyonal na pag-aaral
  • New Jersey Cancer Center, Belleville · 4 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT05236114

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Nagre-recruitPhase 1/2
  • Summit Medical Group (site 205), Florham Park · 12 mi ang layo
  • Atlantic Health System, Morristown Medical Center (site 124), Morristown · 17 mi ang layo
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT03556228

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Newark

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.